跳至主要内容
临床试验/NCT03174470
NCT03174470已完成不适用

Safety Demonstration of Increasing Intensities of Electrical Stimulation Delivered to The Bulbospongiosus Muscle

Virility Medical Ltd.1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2016年11月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Incidence of Treatment-Emergent Adverse Events

研究概览

简要总结

The company suggests a new concept of treatment for PE: Transient inhibition of striated muscle contraction by a transcutaneous stimulation device. This study aim is to evaluate the safety of delivering increasing electrical stimulation intensities to the subject's perineum, using a TENS technique and equipment, followed by a 72-hour postoperative follow-up.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Generally healthy
  • Ability to follow study instructions and complete study assessment tools

排除标准

  • History of cardiovascular disorders
  • Any type of implanted pacemaker/defibrillator
  • Hypertension
  • Diabetes Mellitus
  • Local dermatological disease
  • Local skin irritation/lesions
  • Any neurological disorder
  • Any psychiatric disease and/or psychiatric medications

研究组 & 干预措施

TENS stimulator

Experimental

Single day Transcutaneous electrical nerve stimulations utilizing a commercial TENS stimulator (TensMed S82 ENRAF-NONIUS)

干预措施: TENS Stimulator (Device)

结局指标

主要结局

Incidence of Treatment-Emergent Adverse Events

时间窗: Baseline

Pain sensation score given by all subjects, as well as their verbal description of what they sensed during the various stimulations

次要结局

  • Incidence of post-treatment Adverse Events(72 hours)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验